Cassava Sciences IncNASDAQ:SAVA
- LAST PRICE30.1400
- TODAY'S CHANGE (%)-0.1800 (-0.5937%)
- Bid / Lots30.1200/ 1
- Ask / Lots30.1900/ 4
- Open / Previous Close30.5400 / 30.3200
- Day Range
- 52 Week Range
- Volume1,007,408
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SAVA |
|---|---|---|
| 09:32 ET | 20854 | 31.0033 |
| 09:34 ET | 3004 | 30.9262 |
| 09:36 ET | 4258 | 30.79 |
| 09:38 ET | 7601 | 30.615 |
| 09:39 ET | 2399 | 30.9484 |
| 09:41 ET | 2888 | 30.7428 |
| 09:43 ET | 2371 | 30.9 |
| 09:45 ET | 3435 | 30.68 |
| 09:48 ET | 3830 | 30.78 |
| 09:50 ET | 3347 | 30.89 |
| 09:52 ET | 5651 | 30.91 |
| 09:54 ET | 11240 | 30.8201 |
| 09:56 ET | 9880 | 31.15 |
| 09:57 ET | 6547 | 31.2 |
| 09:59 ET | 6391 | 31.1 |
| 10:01 ET | 27744 | 31.46 |
| 10:03 ET | 37859 | 31.732 |
| 10:06 ET | 19045 | 31.4248 |
| 10:08 ET | 3796 | 31.535 |
| 10:10 ET | 11763 | 31.524 |
| 10:12 ET | 3807 | 31.534 |
| 10:14 ET | 5246 | 31.545 |
| 10:15 ET | 7510 | 31.278 |
| 10:17 ET | 13707 | 31.11 |
| 10:19 ET | 5500 | 31.12 |
| 10:21 ET | 4667 | 31.075 |
| 10:24 ET | 8172 | 30.9 |
| 10:26 ET | 5639 | 30.78 |
| 10:28 ET | 2250 | 30.865 |
| 10:30 ET | 4644 | 30.7 |
| 10:32 ET | 11335 | 30.85 |
| 10:33 ET | 10047 | 30.79 |
| 10:35 ET | 3300 | 30.965 |
| 10:37 ET | 6468 | 30.7 |
| 10:39 ET | 1707 | 30.735 |
| 10:42 ET | 5522 | 30.5805 |
| 10:44 ET | 2374 | 30.63 |
| 10:46 ET | 4328 | 30.6 |
| 10:48 ET | 100 | 30.6 |
| 10:50 ET | 12842 | 30.478 |
| 10:51 ET | 2174 | 30.49 |
| 10:53 ET | 673 | 30.46 |
| 10:55 ET | 2400 | 30.59 |
| 10:57 ET | 2704 | 30.6685 |
| 11:00 ET | 3822 | 30.62 |
| 11:02 ET | 100 | 30.62 |
| 11:04 ET | 1134 | 30.6 |
| 11:06 ET | 10870 | 30.38 |
| 11:08 ET | 4355 | 30.3095 |
| 11:09 ET | 4728 | 30.4105 |
| 11:11 ET | 2751 | 30.42 |
| 11:13 ET | 3877 | 30.39 |
| 11:15 ET | 3223 | 30.46 |
| 11:18 ET | 3192 | 30.4689 |
| 11:20 ET | 1764 | 30.5 |
| 11:22 ET | 300 | 30.54 |
| 11:26 ET | 990 | 30.52 |
| 11:27 ET | 1550 | 30.4399 |
| 11:29 ET | 1205 | 30.5194 |
| 11:31 ET | 1300 | 30.5207 |
| 11:33 ET | 7348 | 30.3986 |
| 11:36 ET | 1865 | 30.51 |
| 11:38 ET | 497 | 30.5852 |
| 11:40 ET | 1063 | 30.54 |
| 11:42 ET | 2933 | 30.54 |
| 11:44 ET | 700 | 30.54 |
| 11:45 ET | 1500 | 30.5519 |
| 11:47 ET | 3198 | 30.55 |
| 11:49 ET | 2692 | 30.58 |
| 11:51 ET | 7546 | 30.595 |
| 11:54 ET | 14792 | 30.58 |
| 11:56 ET | 2461 | 30.65 |
| 11:58 ET | 1821 | 30.79 |
| 12:00 ET | 532 | 30.5818 |
| 12:02 ET | 649 | 30.5921 |
| 12:03 ET | 4119 | 30.8399 |
| 12:05 ET | 5858 | 30.8937 |
| 12:07 ET | 1070 | 30.845 |
| 12:09 ET | 400 | 30.82 |
| 12:12 ET | 5738 | 30.8465 |
| 12:14 ET | 213 | 30.705 |
| 12:16 ET | 1200 | 30.7 |
| 12:18 ET | 8767 | 30.625 |
| 12:20 ET | 41423 | 30.47 |
| 12:21 ET | 7433 | 30.48 |
| 12:23 ET | 2889 | 30.48 |
| 12:25 ET | 18472 | 30.2075 |
| 12:27 ET | 6895 | 30.2516 |
| 12:30 ET | 13571 | 30.285 |
| 12:32 ET | 78158 | 29.85 |
| 12:34 ET | 24526 | 29.83 |
| 12:36 ET | 5329 | 29.92 |
| 12:38 ET | 5339 | 29.9462 |
| 12:39 ET | 10479 | 30 |
| 12:41 ET | 1994 | 29.95772 |
| 12:43 ET | 2597 | 29.9 |
| 12:45 ET | 5188 | 30.18 |
| 12:48 ET | 3102 | 30.15 |
| 12:50 ET | 10483 | 30.0492 |
| 12:52 ET | 2191 | 30.08 |
| 12:54 ET | 5083 | 29.98 |
| 12:56 ET | 6422 | 29.9403 |
| 12:57 ET | 4640 | 29.8798 |
| 12:59 ET | 5888 | 29.9256 |
| 01:01 ET | 1979 | 29.83 |
| 01:03 ET | 6586 | 29.9436 |
| 01:06 ET | 3149 | 29.85 |
| 01:08 ET | 3675 | 29.8499 |
| 01:10 ET | 3063 | 29.7736 |
| 01:12 ET | 4600 | 29.906 |
| 01:14 ET | 802 | 29.86 |
| 01:15 ET | 1110 | 29.92 |
| 01:17 ET | 4540 | 29.895 |
| 01:19 ET | 1632 | 29.85 |
| 01:21 ET | 620 | 29.83 |
| 01:24 ET | 6500 | 29.82 |
| 01:26 ET | 200 | 29.825 |
| 01:28 ET | 1100 | 29.86 |
| 01:30 ET | 1700 | 29.915 |
| 01:32 ET | 2822 | 29.84 |
| 01:33 ET | 1781 | 29.845 |
| 01:35 ET | 1520 | 29.92 |
| 01:37 ET | 1135 | 29.92 |
| 01:39 ET | 1295 | 30 |
| 01:42 ET | 4293 | 29.97 |
| 01:44 ET | 800 | 29.9002 |
| 01:46 ET | 400 | 29.92 |
| 01:48 ET | 300 | 29.955 |
| 01:50 ET | 200 | 29.945 |
| 01:51 ET | 300 | 29.8698 |
| 01:53 ET | 5781 | 29.8 |
| 01:55 ET | 2416 | 29.9087 |
| 01:57 ET | 600 | 29.89 |
| 02:00 ET | 200 | 29.85 |
| 02:02 ET | 1300 | 29.7976 |
| 02:04 ET | 1284 | 29.9 |
| 02:06 ET | 2887 | 29.9 |
| 02:08 ET | 4841 | 29.8601 |
| 02:09 ET | 10423 | 29.86 |
| 02:11 ET | 1303 | 29.8775 |
| 02:13 ET | 1868 | 29.93 |
| 02:15 ET | 350 | 29.93 |
| 02:18 ET | 3522 | 29.87 |
| 02:20 ET | 719 | 29.85 |
| 02:22 ET | 809 | 29.85 |
| 02:24 ET | 6972 | 30 |
| 02:26 ET | 1765 | 30.19 |
| 02:27 ET | 200 | 30.14 |
Sep 9, 2024
DJ Cassava Sciences' Executive Chairman Rick Barry Becomes CEO, from 9:06AM ET on Monday Sep 09, 2024 by Dow Jones
9:06AM ET on Monday Sep 09, 2024 by Dow JonesCassava Sciences Names Rick Barry as Chief Executive Officer, from 8:30AM ET on Monday Sep 09, 2024 by Dow Jones
8:30AM ET on Monday Sep 09, 2024 by Dow JonesPress Release: Cassava Sciences Names Rick Barry as Chief Executive Officer, from 8:30AM ET on Monday Sep 09, 2024 by Dow Jones
8:30AM ET on Monday Sep 09, 2024 by Dow Jones
Sep 3, 2024
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference, from 8:31AM ET on Tuesday Sep 03, 2024 by Dow Jones
8:31AM ET on Tuesday Sep 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cassava Sciences Inc | 1.5B | -74.3x | --- |
Spyre Therapeutics Inc | 1.5B | -2.0x | --- |
Belite Bio Inc | 1.5B | -39.6x | --- |
Disc Medicine Inc | 1.4B | -13.3x | --- |
Syndax Pharmaceuticals Inc | 1.5B | -5.5x | --- |
ARS Pharmaceuticals Inc | 1.4B | -32.0x | --- |
Company Information
Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on neuroscience. The Company's science is based on stabilizing, but not removing, a critical protein in the Alzheimer’s brain. Its scientific approach for the treatment of Alzheimer's disease seeks to simultaneously suppress both neurodegeneration and neuroinflammation. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease dementia. Simufilam targets an altered form of a protein called filamin A (FLNA) in the Alzheimer’s brain. It is conducting two randomized placebo-controlled Phase III clinical trials of oral simufilam in patients with Alzheimer’s disease dementia. SavaDx, its lead investigational diagnostic product candidate, is a way to detect the presence of Alzheimer’s disease from a small sample of blood. SavaDx is a research-use only, non-safety related exploratory biomarker.
Contact Information
- Headquarters
- 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300AUSTIN, TX, United States 78731
- Phone
- 512-501-2444
- Fax
- 512-614-0414
Executives
- Non-Executive Independent Chairman of the Board
- Claude Nicaise
- Chief Executive Officer
- Richard Barry
- Chief Financial Officer
- Eric Schoen
- Senior Vice President, General Counsel
- R. Christopher Cook
- Chief Medical Officer
- James Kupiec
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.5B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 48.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.61 |
EPS | $-0.41 |
Book Value | $3.25 |
P/E Ratio | -74.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
